Despite the diretoria's efforts to reassure investors, the market is likely to react negatively in the short term, as the Q4 earnings call revealed several concerning factors. These include the impact of Johnson & Johnson's (J&J) consumer recalls, continued pricing pressure, and higher operating expenses, which are expected to affect the company's performance in 2011. The stock will likely face pressure over the next two weeks. [-2]